Found: 14
Select item for more details and to access through your institution.
Attenuated cytarabine, etoposide, dexamethasone plus rituximab (R‐Mini‐CYVE) regimen for patients with relapsed or refractory B‐cell non–Hodgkin's lymphoma not eligible for intensive chemotherapy.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 4, p. 574, doi. 10.1111/ejh.13589
- By:
- Publication type:
- Article
Impact of rituximab on stem cell mobilization following ACVBP regimen in poor-risk patients with diffuse large B-cell lymphoma: results from a large cohort of patients.
- Published in:
- Transfusion, 2013, v. 53, n. 1, p. 115, doi. 10.1111/j.1537-2995.2012.03683.x
- By:
- Publication type:
- Article
Repeated courses of low‐dose 2 × 2 Gy radiation therapy in patients with indolent B‐cell non‐Hodgkin lymphomas.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 11, p. 3725, doi. 10.1002/cam4.2796
- By:
- Publication type:
- Article
Work and education interruption in long-term Hodgkin lymphoma survivors: an analysis among patients from nine EORTC-LYSA trials.
- Published in:
- Acta Oncologica, 2023, v. 62, n. 7, p. 744, doi. 10.1080/0284186X.2023.2195561
- By:
- Publication type:
- Article
Combined Linkage and Association Studies Show that HLA Class II Variants Control Levels of Antibodies against Epstein-Barr Virus Antigens.
- Published in:
- PLoS ONE, 2014, v. 9, n. 7, p. 1, doi. 10.1371/journal.pone.0102501
- By:
- Publication type:
- Article
Efficacy and Safety of the Combination of Rituximab, Fludarabine, and Mitoxantrone for Rituximab-Naive, Recurrent/Refractory Follicular Non-Hodgkin Lymphoma With High Tumor Burden.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 18, p. 4299, doi. 10.1002/cncr.25280
- By:
- Publication type:
- Article
Survival After Hodgkin Lymphoma: Causes of Death and Excess Mortality in Patients Treated in 8 Consecutive Trials.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 8, p. 1680, doi. 10.1002/cncr.24178
- By:
- Publication type:
- Article
Employment situation among long-term Hodgkin lymphoma survivors in Europe: an analysis of patients from nine consecutive EORTC-LYSA trials.
- Published in:
- Journal of Cancer Survivorship, 2024, v. 18, n. 3, p. 727, doi. 10.1007/s11764-022-01305-w
- By:
- Publication type:
- Article
Dissemination patterns of Hodgkin lymphoma using a probability network model based on [<sup>18</sup>F]-FDG PET/CT.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 5, p. 1414, doi. 10.1007/s00259-022-06086-z
- By:
- Publication type:
- Article
Poor predictive value of positive interim FDG-PET/CT in primary mediastinal large B-cell lymphoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 12, p. 2018, doi. 10.1007/s00259-017-3758-5
- By:
- Publication type:
- Article
Prognosis of patients with advanced hodgkin's disease.
- Published in:
- Cancer (0008543X), 1997, v. 80, n. 6, p. 1124, doi. 10.1002/(SICI)1097-0142(19970915)80:6<1124::AID-CNCR16>3.0.CO;2-A
- By:
- Publication type:
- Article
Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients.
- Published in:
- Cancer (0008543X), 1996, v. 78, n. 6, p. 1293, doi. 10.1002/(SICI)1097-0142(19960915)78:6<1293::AID-CNCR18>3.0.CO;2-W
- By:
- Publication type:
- Article
Strong Correlations of Anti-Viral Capsid Antigen Antibody Levels in First-Degree Relatives from Families with Epstein-Barr Virus-Related Lymphomas.
- Published in:
- Journal of Infectious Diseases, 2009, v. 199, n. 8, p. 1121, doi. 10.1086/597424
- By:
- Publication type:
- Article
Advanced Hodgkin disease with large mediastinal involvement can be treated with eight cycles of chemotherapy alone after a major response to six cycles of chemotherapy: a study of 82 patients from the Groupes d'Etudes des Lymphomes de l'Adulte H89 trial.
- Published in:
- 2001
- By:
- Publication type:
- journal article